Skip to main content
SpringerLink
Log in

Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschließlich des Karzinosarkoms)

  • Chapter
  • First Online:
Praxisbuch Gynäkologische Onkologie

  • 2675 Accesses

Zusammenfassung

In diesem Kapitel werden die eigentlichen Sarkome des Uterus, das Leiomyosarkom, das undifferenzierte Sarkom, das endometriale Stromasarkom sowie das Adenosarkom besprochen. Das Karzinosarkom, auch maligner, gemischter mesenchymaler Tumor oder maligner, gemischter mesodermaler Tumor (MMT) genannt, ist monoklonalen epithelialen Ursprungs, gehört zu den entdifferenzierten Endometriumkarzinomen und wird im Kapitel der Endometriumkarzinome besprochen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abeler VM, Nenodovic M (2011) Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases. Int J Gynecol Pathol 30(3):236–243

    Article  Google Scholar 

  • Abu-Rustum NR, Curtin JP, Burt M, Jones WB (1997) Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol 89:850–852

    Article  CAS  Google Scholar 

  • Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL (1988) Treatment of uterine leiomyosarcoma. Obstet Gynecol 71:845–850

    CAS  PubMed  Google Scholar 

  • Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr (1990) Treatment of endometrial stromal tumors. Gynecol Oncol 36:60–65

    Article  CAS  Google Scholar 

  • Bodner K, Bodner-Adler B, Obermair A et al (2001) Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 81:160–165

    Article  CAS  Google Scholar 

  • Brooks SE, Zhan M, Cote T, Baquet CR (2004) Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol 93:204–208

    Article  Google Scholar 

  • Burns B, Curry RH, Bell ME (1979) Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases. Am J Obstet Gynecol 135:109–114

    CAS  PubMed  Google Scholar 

  • Chang KL, Crabtree GS et al (1990) Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14:415–438

    Article  CAS  Google Scholar 

  • Evans HL, Chawla SP, Simpson C, Finn KP (1998) Smooth muscle neoplasms of the uterus other than ordinary leiomyomas. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 62(10):2239–2247

    Article  CAS  Google Scholar 

  • Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losa G, Fanucchi A (1996) Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 63:247–253

    Article  CAS  Google Scholar 

  • Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS (2003) Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 89:460–469

    Article  Google Scholar 

  • Hardman MP, Roman JJ, Burnett AF, Santin AD (2007) Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor. Obstet Gynecol 110:518–520

    Article  Google Scholar 

  • Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S (2004) Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101:1455–1462

    Article  CAS  Google Scholar 

  • Leunen M, Breugelmans M, De Sutter P, Bourgain C, Amy J (2004) Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95:769–771

    Article  CAS  Google Scholar 

  • Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF (1993) Prognostic factors in early-stage uterine sarcoma. A gynecologic oncology group study. Cancer 71:1702–1709

    Article  CAS  Google Scholar 

  • Martin-Broto J, Pousa A, De las Penas R, Del Muro G, Gutierrez A, Martinez-Trufero J et al (2016) Randomized phase II study of trabectedin and doxorubicin compared with doxorubicin alone in first-line treatment in patients with advanced soft-tissue sarcomas: A Spanish group for research on sarcoma study. J Clin Oncol 34:2294–2302

    Article  CAS  Google Scholar 

  • Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83:414–418

    CAS  PubMed  Google Scholar 

  • Reed NS, Mangioni C, Malmstrom H et al (2008) Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an EORTC Gynaecological Cancer Group study (protocol 55874). Eur J Cancer 44:808–818

    Article  CAS  Google Scholar 

  • Reich O, Regauer S, Urdl W, Lahousen M, Winter R (2000) Expression of estrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 82:1030–1034

    Article  CAS  Google Scholar 

  • Sutton G, Blessing JA, Malfetano JH (1996a) Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 62:226–229

    Article  CAS  Google Scholar 

  • S2k-Leitlinie Uterussarkom, AWMF-Registernummer 015/074, August 2015. http://www.awmf.org/leitlinien/detail/ll/015-074.html

  • Tap W, Jones R, Van Tine B, Chmielowski B, Elias A, Adkins D et al (2016) Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: An open-label phase 1b and randomised phase 2 trial. Lancet 388:488–497

    Article  CAS  Google Scholar 

  • Van der Graaf W, Blay JY, Chawla S, Kim D, Nguyen B, Casali P et al (2012) Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 379:1879–1886

    Article  Google Scholar 

  • Weitmann HD, Knocke TH, Kucera H, Potter R (2001) Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 49:739–748

    Article  CAS  Google Scholar 

Weiterführende Literatur

  • Chan JK, Kawar NM et al (2008) Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 99:1210–1215

    Article  CAS  Google Scholar 

  • D’Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116(1):131–139

    Article  Google Scholar 

  • Demetri GD, Chawla SP, von Mehren M et al (2009) Efficacy and safety of trabectedin in patients with advanced and metastastic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 27:4188–4196

    Article  CAS  Google Scholar 

  • Ducimetière F, Lurkin A et al (2011) Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One 6(8):e20294

    Article  Google Scholar 

  • FIGO committee on Gynecologic Oncology (2009) FIGO staging for uterine sarcomas. Int J Gynecol Obstet 104:179

    Article  Google Scholar 

  • Gadducci A, Cosio S et al (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65:129–142

    Article  Google Scholar 

  • Garg G, Shah JP et al (2010) Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 118:8–13

    Article  CAS  Google Scholar 

  • Goff BA, Rice LW, Fleischhacker D, Muntz HG, Falkenberry SS, Nikrui N, Fuller AF Jr (1993) Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol Jul;50(1):105–109

    Article  CAS  Google Scholar 

  • Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, Sabbatini P, Tong W, Barakat R, Spriggs DR (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20:2824–2831

    Article  CAS  Google Scholar 

  • Hensley ML et al (2009) „Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study.“ Gynecol Oncol 112(3):563–567

    Article  CAS  Google Scholar 

  • Hensley ML et al (2013) „Adjuvant therapy for high-grade, uterine-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)“. Cancer 119(8):1555–1561

    Article  CAS  Google Scholar 

  • Jones MW, Norris HJ (1995) Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 14(3):243–249

    Article  CAS  Google Scholar 

  • Kurihara S, Oda Y et al (2008) Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. Am J Surg Pathol 32:1228–1238

    Article  Google Scholar 

  • Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS (2003) Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 91:209–212

    Article  Google Scholar 

  • Lissoni A, Cormio G, Perego P, Gabriele A, Cantu MG, Bratina G (1997) Conservative management of endometrial stromal sarcoma in young women. Int J Gynecol Cancer 7:364–367

    Article  Google Scholar 

  • Li N, Wu LY, Zhang HT, An JS, Li XG, Ma SK (2008) Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol 108(2):306–311

    Article  Google Scholar 

  • Leath CA 3rd, Huh WK et al (2007) A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 105:630–634

    Article  Google Scholar 

  • Lee CH, Ou WB, Marino-Enriquez A et al (2012) 14-3-3 fusion oncogene in high-grade endometrial stromal sarcoma. Proc natl Acad Sci USA 109:929–934

    Article  CAS  Google Scholar 

  • Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS (2009) Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience. Int J Gynecol Cancer 19(6):1080–1084

    Article  Google Scholar 

  • Malouf GG, Duclos J et al (2010) Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma. Ann Oncol 21:2102–2106

    Article  CAS  Google Scholar 

  • Muss HB, Bundy BN, DISaia PJ, Homesley HD, Fowler WC, Creasman W, Yordan E (1985) Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide: a phase III trial of the Gynecologic Oncology Group. Cancer 55:1648–1653

    Article  CAS  Google Scholar 

  • Nordal RN, Kjorstad KE, Stenwig AE, Trope CG (1993) Leiomyosarcoma and endometrial stromal sarcoma of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985. Int J Gynecol Cancer 3:110–115

    Article  Google Scholar 

  • Okuno S, Edmonson J, Mahoney M, Buckner JC, Frytak S, Galanis E (2002) Phase II trial of gemcitabine in advanced sarcomas. Cancer 94:3225–3229

    Article  CAS  Google Scholar 

  • Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, Zaino RT (1983) A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52:626–632

    Article  CAS  Google Scholar 

  • Omura GA, Blessing JA, Major FA (1985) A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a gynecologic oncology group study. J Clin Oncol 3:1240–1245

    Article  CAS  Google Scholar 

  • Pautier P, Genestie C et al (2000) Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88:1425–1431

    Article  CAS  Google Scholar 

  • Pautier P, Floquet A et al (2012) A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study) A study of the French Sarcoma Group. Ann Oncol 24:1099–1104

    Article  Google Scholar 

  • Peters WA 3rd, Howard DR, Andersen WA, Figge DC (1994) Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 83:1015–1020

    Article  Google Scholar 

  • Petru E, Lück HJ, Stuart G, Gaffney D, Millan D, Vergote I (2009) Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 143:69–74

    Article  Google Scholar 

  • Riopel J, Plante M, Renaud M-C, Roy M, Têtu B (2005) Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 96:402–406

    Article  CAS  Google Scholar 

  • Sanfilippo R, Grosso F, Jones RL et al (2011) Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers. Gynecol Oncol Sep 12

    Google Scholar 

  • Sutton GP, Blessing JA, Barrett RJ, McGehee R (1992) Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a gynecologic oncology group study. Am J Obstet Gynecol 166:556–559

    Article  CAS  Google Scholar 

  • Sutton G, Blessing JA, Park R, DiSaia PJ, Rosenshein N (1996b) Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the gynecologic oncology group. Obstet Gynecol 87:747–750

    Article  CAS  Google Scholar 

  • Tanner EJ, Garg K et al (2012) High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 127:27–31

    Article  Google Scholar 

  • Wade K, Quinn MA, Hammond I, Williams K, Cauchi M (1990) Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 39:364–367

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gynäkologie, UniversitätsSpital Zürich, Zürich, Schweiz

    Patrick Imesch & Daniel Fink

  2. Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Österreich

    Edgar Petru

Authors
  1. Patrick Imesch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edgar Petru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick Imesch .

Editor information

Editors and Affiliations

  1. Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Austria

    Edgar Petru

  2. Klinik für Gynäkologie, UniversitätsSpital Zürich, Zürich, Switzerland

    Daniel Fink

  3. Gynäkologisch-onkologische Praxis, BrustCentrum, Privatklinik Zürich-Bethanien, Zürich, Switzerland

    Ossi R. Köchli

  4. German Breast Group Forschungs GmbH, Neu-Isenburg, Germany

    Sibylle Loibl

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Imesch, P., Petru, E., Fink, D. (2019). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschließlich des Karzinosarkoms). In: Petru, E., Fink, D., Köchli, O., Loibl, S. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57430-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57430-0_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57429-4

  • Online ISBN: 978-3-662-57430-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation